Daniel O'Connell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Executive Officer | $646,354 | $1,863,567 |
| 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Executive Officer | $621,494 | $4,780,687 |
| 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Executive Officer | $597,590 | $3,930,011 |
| 2022 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Executive Officer | $570,492 | $2,662,052 |
| 2021 | Acumen Pharmaceuticals, Inc. (ABOS) | President and Chief Executive Officer | $524,597 | $1,477,836 |
| 2020 | Acumen Pharmaceuticals, Inc. (ABOS) | President and Chief Executive Officer | $240,000 | $336,000 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.